Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 5909-5916
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.5909
Table 2 Endoscopic retrograde cholangio-pancreatography pancreatitis rates in endoscopic papillary balloon dilatation and endoscopic sphincterotomy in ramdomized control trials
Ref.Study designYearTotal patientsSignificant difference from the control
Percentage of PEP
Balloon size (mm)Maximum pressure (atm)Ballooning time (s)Dilatation speedNote
Therapuetic successML usePEP rateEPBDEST
SignificantFujita et al[33]RCT2003282--EPBD > EST10.92.88Waist disappear153 min
Disario et al[2]RCT2004237--EPBD > EST10.30.88Maximum60NM2 deaths in EPBD
Watanabe et al[34]RCT2007180EST > EPBDEPBD > ESTEPBD > EST16.76.787120NM
Non-significantMinami et al[35]RCT199540---10.010.08NM180NMManometry
Bergman et al[36]RCT1997202-EPBD > EST-6.96.981245-601-2 min1 death in EPBD
Ochi et al[37]RCT1999110EST > EPBD--03.78860 × 3 timesNM
Arnold et al[38]RCT200160EST > EPBDNM-20.010.081060 × 2 timesNM
Yasuda et al[22]RCT200170-EPBD > EST-5.75.78660 × 2 timesNMManometry
Bergman et al[13]RCT200134---6.2081045-601-2 minBillroth II
Natsui et al[39]RCT2002140---5.74.388120NM
Vlavianos et al[40]RCT2003202---4.81.0101230NM
Tanaka et al[41]RCT200432---18.818.888120NMLong-term outcome
Seo et al[25]RCT2014132---8.17.16-10Stone size90-120GraduallyAge < 40 yr